Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL21800937 | 0.99 | TLR7 (0.74) | TLR7TLR8 | |
| SCHEMBL20487088 | 0.96 | TLR7 (0.69) | TLR7TLR8 | |
| Hydrochloric Acid SCHEMBL20487571 | 0.95 | TLR7 (0.68) | TLR7TLR8 | |
| SCHEMBL23652508 | 0.93 | TLR7 (0.72) | TLR7TLR8 | |
| SCHEMBL22400042 | 0.92 | TLR7 (0.70) | TLR7TLR8 | |
| Hydrochloric Acid SCHEMBL20488423 | 0.91 | TLR7 (0.69) | TLR7TLR8 | |
| SCHEMBL20487558 | 0.91 | TLR7 (0.70) | TLR7TLR8 | |
| SCHEMBL3867030 | 0.90 | TLR7 (0.79) | TLR7TLR8 | |
| Hydrochloric Acid SCHEMBL20487490 | 0.90 | TLR7 (0.69) | TLR7TLR8 | |
| SCHEMBL26351069 | 0.90 | TLR7 (0.79) | TLR7TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3589631-B1 | IMIDAZO[4,5-C]RING COMPOUNDS CONTAINING GUANIDINE SUBSTITUTED BENZAMIDE GROUPS | 3M INNOVATIVE PROPERTIES CO (US) | 2021-07-21 | — | — | EP | disclosed |
| US-10766896-B2 | Imidazo[4,5-c] ring compounds containing guanidine substituted benzamide groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-09-08 | — | — | US | disclosed |
| WO-2018160552-A1 | IMIDAZO[4,5-c] RING COMPOUNDS CONTAINING GUANIDINE SUBSTITUTED BENZAMIDE GROUPS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-09-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10766896-B2 | Imidazo[4,5-c] ring compounds containing guanidine substituted benzamide groups | IL4, IFNG, IFNAR1 | TLR7 105/4885TLR8 213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.